Evidence map›Paper›PMID 35967980›Full record

ArticlePNAS nexus2022

Establishment of blood glycosidase activities and their excursions in sepsis.

Benjamin S Haslund-Gourley, Peter V Aziz, Douglas M Heithoff, Damien Restagno, Jeffrey C Fried, Mai-Britt Ilse, Hannah Bäumges, Michael J Mahan, Torben Lübke, Jamey D Marth

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PNAS nexus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Benjamin S Haslund-GourleySanford-Burnham-Prebys Medical Discovery Institute, Infectious and Inflammatory Diseases Center, La Jolla, CA 92037, USA.ORCID https://orcid.org/0000-0002-8488-0759
Peter V AzizSanford-Burnham-Prebys Medical Discovery Institute, Infectious and Inflammatory Diseases Center, La Jolla, CA 92037, USA.
Douglas M HeithoffDepartment of Molecular, Cellular, and Developmental Biology, University of California Santa Barbara, CA 93106, USA.
Damien RestagnoSanford-Burnham-Prebys Medical Discovery Institute, Infectious and Inflammatory Diseases Center, La Jolla, CA 92037, USA.ORCID https://orcid.org/0000-0002-5120-7787
Jeffrey C FriedDepartment of Pulmonary and Critical Care Medicine, Cottage Hospital of Santa Barbara, Santa Barbara, CA 93105, USA.
Mai-Britt IlseDepartment of Chemistry, Biochemistry, Bielefeld University, D-33615, Germany.
Hannah BäumgesDepartment of Chemistry, Biochemistry, Bielefeld University, D-33615, Germany.
Michael J MahanDepartment of Molecular, Cellular, and Developmental Biology, University of California Santa Barbara, CA 93106, USA.ORCID https://orcid.org/0000-0002-0103-4099
Torben LübkeDepartment of Chemistry, Biochemistry, Bielefeld University, D-33615, Germany.ORCID https://orcid.org/0000-0002-3342-0090
Jamey D MarthSanford-Burnham-Prebys Medical Discovery Institute, Infectious and Inflammatory Diseases Center, La Jolla, CA 92037, USA.ORCID https://orcid.org/0000-0001-9323-1649
Sanford Burnham Prebys Medical Discovery Institute · USBielefeld University · DEUniversity of California, Santa Barbara · USSanta Barbara Cottage Hospital · US

Funding

Protein Glycosylation in the Coagulopathy and Inflammation of SepsisP01HL131474 · NHLBI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MARTH, JAMEY · 2016 to 2025
$26.2M
GLYCOSYLTRANSFERASE FUNCTION IN DEVELOPMENT AND DISEASER01DK048247 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JAMEY MARTH · 1994 to 2026
$9.4M
Protein Sialylation and De-Sialyation in Cell Surface Glycoprotein Homeostasis and DiseaseR01AI151371 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MARTH, JAMEY · 2021 to 2025
$2.4M
NHLBI NIH HHS P01 HL131474NIAID NIH HHS R01 AI151371NIDDK NIH HHS R01 DK048247
6 · The paper itself

Abstract

Glycosidases are hydrolytic enzymes studied principally in the context of intracellular catabolism within the lysosome. Therefore, glycosidase activities are classically measured in experimentally acidified assay conditions reflecting their low pH optima. However, glycosidases are also present in the bloodstream where they may retain sufficient activity to participate in the regulation of glycoprotein half-lives, proteostasis, and disease pathogenesis. We have, herein, established at physiological pH 7.4 in blood plasma and sera the normal ranges of four major glycosidase activities essential for blood glycoprotein remodeling in healthy mice and humans. These activities included β-galactosidase, β-N-acetylglucosaminidase, α-mannosidase, and α-fucosidase. We have identified their origins to include the mammalian genes

Identifiers

PMID35967980
PMCPMC9364217
OpenAlexW4285006528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.